Rifampicin and isoniazid increase acetaminophen and isoniazid cytotoxicity in human HepG2 hepatoma cells

被引:35
作者
Nicod, L
Viollon, C
Regnier, A
Jacqueson, A
Richert, L
机构
[1] FAC MED & PHARM,BIOL CELLULAIRE LAB,F-25030 BESANCON,FRANCE
[2] FAC MED & PHARM,TOXICOL LAB,F-25030 BESANCON,FRANCE
来源
HUMAN & EXPERIMENTAL TOXICOLOGY | 1997年 / 16卷 / 01期
关键词
HepG2; cytotoxicity/drug interactions; acetaminophen; isoniazid; rifampicin;
D O I
10.1177/0960327197016001061
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
Acetaminophen (APAP) induced a concentration-dependent (0-30 mM) cytotoxic effect in human HepG2 hepatoma cells which was significantly increased when intracellular reduced glutathione (GSH) content was decreased. The cytotoxic effect of APAP (0-30 mM) was significantly lower in day 3-treated compared to day 1-treated HepG2 cells, A 3-day preincubation of HepG2 cells with 5 mu M 3-methylcholanthrene (3MC), 50 mu M rifampicin (RFP) or 1 mM isoniazid (INH) significantly increased 15-30 mM APAP cytotoxicity, of about 15-20% for INH and RFP and 35-50% for 3MC. The cytotoxicity of 10 mM APAP was also increased (about 20%) by a 3-day preincubation with INH but was not affected by 3MC and RFP. INH induced a concentration-dependent (0-40 mM) cytotoxic effect in day-1 treated HepG2 cells and not significantly affected by decreases in intracellular GSH concentrations. INH was not cytotoxic in day 3-treated HepG2 cells. A 3-day preincubation of HepG2 cells with 50 mu M RFP or 1 mM INH significantly increased 10-40 mM INH cytotoxicity, respectively of about 10% and 10-25%. A 3-day preincubation with 3MC did not modify the cytotoxic effect of INH at these concentrations. This is to our knowledge the first report of increases by INH and RFP of APAP and INH cytotoxicity in vitro in hepatocellular cells of human origin, It is in accordance with clinical observations of severe hepatotoxicity associated with APAP or INK usage in patients receiving multiple drug therapy (INH, RFP) for tuberculosis or in alcoholics.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 39 条
[1]
BLAAUBOER BJ, 1994, ATLA-ALTERN LAB ANIM, V22, P231
[2]
ENZYME-CATALYSED CONJUGATIONS OF GLUTATHIONE WITH UNSATURATED COMPOUNDS [J].
BOYLAND, E ;
CHASSEAUD, LF .
BIOCHEMICAL JOURNAL, 1967, 104 (01) :95-+
[3]
CARMICHAEL J, 1987, CANCER RES, V47, P936
[4]
DAI Y, 1995, J PHARMACOL EXP THER, V273, P1497
[5]
EVALUATION OF A HUMAN HEPATOMA-CELL LINE AS A TARGET-CELL IN GENETIC TOXICOLOGY [J].
DEARFIELD, KL ;
JACOBSONKRAM, D ;
BROWN, NA ;
WILLIAMS, JR .
MUTATION RESEARCH, 1983, 108 (1-3) :437-449
[6]
DONATO MT, 1995, DRUG METAB DISPOS, V23, P553
[7]
VARIATION IN DRUG-METABOLIZING ENZYME-ACTIVITIES DURING THE GROWTH OF HUMAN HEP G2 HEPATOMA-CELLS [J].
DOOSTDAR, H ;
DEMOZ, A ;
BURKE, MD ;
MELVIN, WT ;
GRANT, MH .
XENOBIOTICA, 1990, 20 (04) :435-441
[8]
THE INFLUENCE OF CULTURE-MEDIUM COMPOSITION ON DRUG-METABOLIZING ENZYME-ACTIVITIES OF THE HUMAN-LIVER DERIVED HEP-G2 CELL-LINE [J].
DOOSTDAR, H ;
DUTHIE, SJ ;
BURKE, MD ;
MELVIN, WT ;
GRANT, MH .
FEBS LETTERS, 1988, 241 (1-2) :15-18
[9]
DOOTSDAR H, 1993, BIOCHEM PHARMACOL, V46, P629
[10]
BROMOBENZENE DETOXIFICATION IN THE HUMAN LIVER-DERIVED HEPG2 CELL-LINE [J].
DUTHIE, SJ ;
MELVIN, WT ;
BURKE, MD .
XENOBIOTICA, 1994, 24 (03) :265-279